Skip to content
Zymatic is an enzyme-based treatment technology for treatment of unwanted organic compounds. The enzymes are selected based on treatment needs and bound to a sand-like material. The solution is flexible, easy to install and to operate.
Zymatic is an enzyme-based treatment technology for treatment of unwanted organic compounds. The enzymes are selected based on treatment needs and bound to a sand-like material. The solution is flexible, easy to install and to operate.

Press release -

Pharem receives funding from NEFCO

SInce the launch of Zymatic earlier this year, Pharem have successfully increased their portfolio of customer related projects, both in the Nordic countries but also internationally. To accelerate these projects Pharem have been granted financing from Nefco.

The release of manmade organic pollutants, such as pharmaceutical residues, plastics, and pesticides, through wastewater streams is a growing concern because they can contaminate marine habitats and waterways. Pharem have developed enzyme-based wastewater treatment solutions that are targeting this concern and preventing such pollutants from being released into waterways.

The technology platform Zymatic uses natural degradation agents, i.e., enzymes, to treat wastewater at treatment plants, industrial streams, or other water environments to treat unwanted organic compounds. The combination of enzymes, material and enzyme immobilisation techniques provides a flexible approach for applying a wide range of treatment mechanisms for the treatment of organic micropollutants (such as pharmaceutical residues, pesticides, plastic chemicals etc.). Using the Zymatic platform, you can apply a wide range of enzymes to the treatment step, and this offers unique adaptability to local needs.

“We see great interest in our technology and have successfully increased our pipeline of customer projects this year. Nefco has a strong network within the cleantech industry. The funding from Nefco is timely as it will enable us to accelerate these projects, reach our goals and further expand our operations into selected strategic markets”, says Martin Ryen, CEO, Pharem Biotech.

About Nefco and Fast-track financing for Nordic SMEs

Nefco is an international financial institution, the Nordic Green Bank, that finances the initial scale-up of Nordic green solutions on global markets. Founded in 1990 by the five Nordic countries, Nefco has already financed and implemented over 1,500 projects in energy efficiency, renewable energy, clean water and sanitation, waste management, and cleaner industrial processes, among others. To date, more than 600 Nordic growth companies have received financing from Nefco to scale up their green technologies and solutions on global markets. We serve the interests of our owners, Denmark, Finland, Iceland, Norway and Sweden, and work with concrete actions to accelerate the green transition. Read more about us on www.nefco.int.

The Green Recovery Loan Programme is targeted for Nordic small and medium-sized companies. The green recovery financing can be used to finance investments and business activities in support of international growth outside the Nordic countries. 

Related links

Topics

Categories


Pharem is specialized in enzymatic treatment of wastewater to remove organic micro-pollutants.

We use our broad biotechnology expertise to develop innovative enzymatic products which provide an effective means of removing organic pollutants in water environments. Our products are specifically developed to meet client needs for simple, effective solutions to tackle serious environmental issues within their operational scope.

Through close, ongoing collaboration with stakeholders, we are constantly working toward meeting customer’s requirements and exceeding expectations by providing safe, innovative, and cost-efficient products to counteract the impact organic pollutants have on the environment.

Contacts

Christian Ryen

Christian Ryen

Press contact COO +46702568414

Related content

Passion for Water Sustainability

Pharem is ​specialized in ​enzymatic ​treatment of ​wastewater to ​remove organic ​micro-pollutants.​

We use our ​broad ​biotechnology ​expertise to ​develop ​innovative ​enzymatic ​products which ​provide an ​effective means ​of removing ​organic ​pollutants in ​water ​environments. ​Our products ​are specifically ​developed to ​meet client ​needs for ​simple, ​effective ​solutions to ​tackle serious ​environmental ​issues within ​their ​operational ​scope. ​

Through close,​ ongoing ​collaboration ​with stakeholders,​ we are ​constantly ​working toward ​meeting ​customer’​s requirements ​and ​exceeding ​expectations by ​providing safe, ​innovative, and ​cost-efficient ​products to ​counteract the ​impact organic ​pollutants have ​on the ​environment. ​

Pharem Biotech AB
Forskargatan 20J
15136 Södertälje
Sverige